{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T10:50:33Z","timestamp":1794999033633,"version":"4.9.1"},"reference-count":245,"publisher":"BMJ","issue":"Suppl 1","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Thorax"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1136\/thoraxjnl-2017-211321","type":"journal-article","created":{"date-parts":[[2018,2,14]],"date-time":"2018-02-14T12:45:18Z","timestamp":1518612318000},"page":"i1-i30","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":181,"title":["British Thoracic Society Guideline for the investigation and management of malignant pleural mesothelioma"],"prefix":"10.1136","volume":"73","clinical-trial-number":[{"clinical-trial-number":"nct03063450","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Ian","family":"Woolhouse","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lesley","family":"Bishop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liz","family":"Darlison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Duneesha","family":"De Fonseka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony","family":"Edey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Edwards","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corinne","family":"Faivre-Finn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dean A","family":"Fennell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steve","family":"Holmes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keith M","family":"Kerr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Apostolos","family":"Nakas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim","family":"Peel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Najib M","family":"Rahman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Slade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremy","family":"Steele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Selina","family":"Tsim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nick A","family":"Maskell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2018,2,14]]},"reference":[{"key":"2020050723442962000_73.Suppl_1.i1.1","unstructured":"National Lung Cancer Audit: Pleural Mesothelioma Report: Royal College of Physicians, 2016."},{"key":"2020050723442962000_73.Suppl_1.i1.2","doi-asserted-by":"publisher","DOI":"10.1136\/thx.2007.087619"},{"key":"2020050723442962000_73.Suppl_1.i1.3","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.lungcan.2015.03.005","article-title":"Demographics, management and survival of patients with malignant pleural mesothelioma in the National Lung Cancer Audit in England and Wales","volume":"88","author":"Beckett","year":"2015","journal-title":"Lung Cancer"},{"key":"2020050723442962000_73.Suppl_1.i1.4","doi-asserted-by":"publisher","DOI":"10.1136\/thx.52.6.507"},{"key":"2020050723442962000_73.Suppl_1.i1.5","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1002\/ajim.20780","article-title":"Case-control study of pleural mesothelioma in workers with social security in Mexico","volume":"53","author":"Aguilar-Madrid","year":"2010","journal-title":"Am J Ind Med"},{"key":"2020050723442962000_73.Suppl_1.i1.6","unstructured":"Peto J . Health and Safety Executive. RR696: Occupational, domestic and environmental mesothelioma risks in Britain. 2009."},{"key":"2020050723442962000_73.Suppl_1.i1.7","doi-asserted-by":"publisher","DOI":"10.1023\/A:1007691003600"},{"key":"2020050723442962000_73.Suppl_1.i1.8","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1038\/modpathol.2015.65","article-title":"BAP1 (BRCA1-associated protein 1) is a highly specific marker for differentiating mesothelioma from reactive mesothelial proliferations","volume":"28","author":"Cigognetti","year":"2015","journal-title":"Mod Pathol"},{"key":"2020050723442962000_73.Suppl_1.i1.9","doi-asserted-by":"publisher","DOI":"10.1159\/000321370"},{"key":"2020050723442962000_73.Suppl_1.i1.10","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19861001)58:7<1540::AID-CNCR2820580727>3.0.CO;2-5"},{"key":"2020050723442962000_73.Suppl_1.i1.11","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1016\/j.jtho.2016.09.124","article-title":"The IASLC Mesothelioma Staging Project: Proposals for the M Descriptors and for Revision of the TNM Stage Groupings in the Forthcoming (Eighth) Edition of the TNM Classification for Mesothelioma","volume":"11","author":"Rusch","year":"2016","journal-title":"J Thorac Oncol"},{"key":"2020050723442962000_73.Suppl_1.i1.12","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1200\/JCO.1993.11.6.1172","article-title":"Node status has prognostic significance in the multimodality therapy of diffuse, malignant mesothelioma","volume":"11","author":"Sugarbaker","year":"1993","journal-title":"J Clin Oncol"},{"key":"2020050723442962000_73.Suppl_1.i1.13","doi-asserted-by":"publisher","DOI":"10.1136\/thoraxjnl-2014-206054"},{"key":"2020050723442962000_73.Suppl_1.i1.14","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1177\/028418518602700507","article-title":"Computed tomography of pleural lesions with special reference to the mediastinal pleura","volume":"27","author":"Salonen","year":"1986","journal-title":"Acta Radiol Diagn"},{"key":"2020050723442962000_73.Suppl_1.i1.15","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.ejrad.2008.02.004","article-title":"Malignant pleural mesothelioma: computed tomography and correlation with histology","volume":"70","author":"Seely","year":"2009","journal-title":"Eur J Radiol"},{"key":"2020050723442962000_73.Suppl_1.i1.16","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.clinimag.2005.12.027","article-title":"Computed tomography findings in 66 patients with malignant pleural mesothelioma due to environmental exposure to asbestos","volume":"30","author":"Okten","year":"2006","journal-title":"Clin Imaging"},{"key":"2020050723442962000_73.Suppl_1.i1.17","doi-asserted-by":"publisher","DOI":"10.1080\/028418501127347070"},{"key":"2020050723442962000_73.Suppl_1.i1.18","doi-asserted-by":"publisher","DOI":"10.1016\/S0720-048X(01)00426-0"},{"key":"2020050723442962000_73.Suppl_1.i1.19","doi-asserted-by":"publisher","DOI":"10.1378\/chest.118.3.604"},{"key":"2020050723442962000_73.Suppl_1.i1.20","doi-asserted-by":"publisher","DOI":"10.2214\/ajr.154.3.2106209"},{"key":"2020050723442962000_73.Suppl_1.i1.21","doi-asserted-by":"crossref","first-page":"17","DOI":"10.4081\/monaldi.2005.653","article-title":"CT in differential diagnosis of benign and malignant pleural disease","volume":"63","author":"Yilmaz","year":"2005","journal-title":"Monaldi Arch Chest Dis"},{"key":"2020050723442962000_73.Suppl_1.i1.22","doi-asserted-by":"publisher","DOI":"10.1136\/thx.2008.100545"},{"key":"2020050723442962000_73.Suppl_1.i1.23","first-page":"187","article-title":"The role of FDG PET-CT in differential diagnosis of pleural pathologies","volume":"31","author":"Elboga","year":"2012","journal-title":"Rev Esp Med Nucl Imagen Mol"},{"key":"2020050723442962000_73.Suppl_1.i1.24","doi-asserted-by":"publisher","DOI":"10.1378\/chest.14-0820"},{"key":"2020050723442962000_73.Suppl_1.i1.25","doi-asserted-by":"publisher","DOI":"10.1378\/chest.114.3.713"},{"key":"2020050723442962000_73.Suppl_1.i1.26","first-page":"333","article-title":"Clinical implications of 18F-fluorodeoxyglucose positron emission tomography\/computed tomography at delayed phase for diagnosis and prognosis of malignant pleural mesothelioma","volume":"27","author":"Abe","year":"2012","journal-title":"Oncol Rep"},{"key":"2020050723442962000_73.Suppl_1.i1.27","doi-asserted-by":"publisher","DOI":"10.1097\/JTO.0b013e3181c0a7ff"},{"key":"2020050723442962000_73.Suppl_1.i1.28","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.acra.2013.09.015","article-title":"Diagnostic accuracy of 18F-FDG-PET and PET\/CT in the differential diagnosis between malignant and benign pleural lesions: a systematic review and meta-analysis","volume":"21","author":"Treglia","year":"2014","journal-title":"Acad Radiol"},{"key":"2020050723442962000_73.Suppl_1.i1.29","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.12110872"},{"key":"2020050723442962000_73.Suppl_1.i1.30","doi-asserted-by":"crossref","first-page":"18","DOI":"10.5271\/sjweh.378","article-title":"Magnetic resonance appearance of asbestos-related benign and malignant pleural diseases","volume":"25","author":"Boraschi","year":"1999","journal-title":"Scand J Work Environ Health"},{"key":"2020050723442962000_73.Suppl_1.i1.31","doi-asserted-by":"crossref","unstructured":"Revelli M , Chiesa F , Del Prato A , et al . Role of respiratory-triggered diffusion-weighted MRI in the assessment of pleural disease. Br J Radiol 2016. doi:10.1259\/bjr.20160289. [Epub ahead of print 29 Jun 2016].","DOI":"10.1259\/bjr.20160289"},{"key":"2020050723442962000_73.Suppl_1.i1.32","doi-asserted-by":"publisher","DOI":"10.2214\/AJR.09.3519"},{"key":"2020050723442962000_73.Suppl_1.i1.33","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1148\/radiol.14132111","article-title":"Malignant pleural mesothelioma: visual assessment by using pleural pointillism at diffusion-weighted MR imaging","volume":"274","author":"Coolen","year":"2015","journal-title":"Radiology"},{"key":"2020050723442962000_73.Suppl_1.i1.34","doi-asserted-by":"publisher","DOI":"10.1378\/chest.129.6.1570"},{"key":"2020050723442962000_73.Suppl_1.i1.35","doi-asserted-by":"publisher","DOI":"10.3816\/CLC.2009.n.033"},{"key":"2020050723442962000_73.Suppl_1.i1.36","doi-asserted-by":"publisher","DOI":"10.1097\/RLI.0b013e3181817b3d"},{"key":"2020050723442962000_73.Suppl_1.i1.37","doi-asserted-by":"publisher","DOI":"10.1016\/S1010-7940(03)00609-2"},{"key":"2020050723442962000_73.Suppl_1.i1.38","doi-asserted-by":"publisher","DOI":"10.1016\/S0003-4975(03)00010-9"},{"key":"2020050723442962000_73.Suppl_1.i1.39","doi-asserted-by":"publisher","DOI":"10.2214\/ajr.172.4.10587144"},{"key":"2020050723442962000_73.Suppl_1.i1.40","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1016\/j.clinimag.2013.06.009","article-title":"18F-FDG PET\/CT in suspected recurrences of epithelial malignant pleural mesothelioma in asbestos-fibers-exposed patients (comparison to standard diagnostic follow-up)","volume":"37","author":"Niccoli-Asabella","year":"2013","journal-title":"Clin Imaging"},{"key":"2020050723442962000_73.Suppl_1.i1.41","doi-asserted-by":"publisher","DOI":"10.1016\/S0169-5002(98)00083-X"},{"key":"2020050723442962000_73.Suppl_1.i1.42","doi-asserted-by":"publisher","DOI":"10.2214\/ajr.159.5.1414807"},{"key":"2020050723442962000_73.Suppl_1.i1.43","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1016\/j.jtcvs.2004.10.034","article-title":"Integrated computed tomography-positron emission tomography in patients with potentially resectable malignant pleural mesothelioma: Staging implications","volume":"129","author":"Erasmus","year":"2005","journal-title":"J Thorac Cardiovasc Surg"},{"key":"2020050723442962000_73.Suppl_1.i1.44","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/s11547-006-0034-3","article-title":"Imaging before and after multimodal treatment for malignant pleural mesothelioma","volume":"111","author":"Fiore","year":"2006","journal-title":"Radiol Med"},{"key":"2020050723442962000_73.Suppl_1.i1.45","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5223(03)00207-1"},{"key":"2020050723442962000_73.Suppl_1.i1.46","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1097\/RCT.0000000000000174","article-title":"Use of Computed Tomography and Positron Emission Tomography\/Computed Tomography for Staging of Local Extent in Patients With Malignant Pleural Mesothelioma","volume":"39","author":"Frauenfelder","year":"2015","journal-title":"J Comput Assist Tomogr"},{"key":"2020050723442962000_73.Suppl_1.i1.47","doi-asserted-by":"publisher","DOI":"10.7785\/tcrt.2012.500245"},{"key":"2020050723442962000_73.Suppl_1.i1.48","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.lungcan.2016.01.017","article-title":"Diagnostic accuracy of sequential co-registered PET+MR in comparison to PET\/CT in local thoracic staging of malignant pleural mesothelioma","volume":"94","author":"Martini","year":"2016","journal-title":"Lung Cancer"},{"key":"2020050723442962000_73.Suppl_1.i1.49","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1159\/000381922","article-title":"Positron Emission Tomography\/Computed Tomography for the Pleural Staging of Malignant Pleural Mesothelioma: How Accurate Is It?","volume":"89","author":"Pinelli","year":"2015","journal-title":"Respiration"},{"key":"2020050723442962000_73.Suppl_1.i1.50","doi-asserted-by":"publisher","DOI":"10.1510\/icvts.2010.255893"},{"key":"2020050723442962000_73.Suppl_1.i1.51","doi-asserted-by":"publisher","DOI":"10.1510\/icvts.2010.255901"},{"key":"2020050723442962000_73.Suppl_1.i1.52","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtho.2015.11.005"},{"key":"2020050723442962000_73.Suppl_1.i1.53","doi-asserted-by":"publisher","DOI":"10.5858\/arpa.2012-0214-OA"},{"key":"2020050723442962000_73.Suppl_1.i1.54","doi-asserted-by":"publisher","DOI":"10.1309\/AJCPT94JVWIHBKRD"},{"key":"2020050723442962000_73.Suppl_1.i1.55","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1111\/cas.12769","article-title":"Deletion status of p16 in effusion smear preparation correlates with that of underlying malignant pleural mesothelioma tissue","volume":"106","author":"Hida","year":"2015","journal-title":"Cancer Sci"},{"key":"2020050723442962000_73.Suppl_1.i1.56","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/978-3-642-10862-4_4","article-title":"Biopsy techniques for the diagnosis of mesothelioma","volume":"189","author":"Walters","year":"2011","journal-title":"Recent Results Cancer Res"},{"key":"2020050723442962000_73.Suppl_1.i1.57","doi-asserted-by":"publisher","DOI":"10.1097\/PAT.0b013e32835bc848"},{"key":"2020050723442962000_73.Suppl_1.i1.58","doi-asserted-by":"crossref","unstructured":"Cui A , Jin XG , Zhai K , et al . Diagnostic values of soluble mesothelin-related peptides for malignant pleural mesothelioma: updated meta-analysis. BMJ Open 2014;4:e004145.","DOI":"10.1136\/bmjopen-2013-004145"},{"key":"2020050723442962000_73.Suppl_1.i1.59","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.cca.2014.02.024","article-title":"Diagnostic accuracy of osteopontin for malignant pleural mesothelioma: a systematic review and meta-analysis","volume":"433","author":"Hu","year":"2014","journal-title":"Clin Chim Acta"},{"key":"2020050723442962000_73.Suppl_1.i1.60","first-page":"1289","article-title":"Performance of osteopontin in the diagnosis of malignant pleural mesothelioma: a meta-analysis","volume":"7","author":"Lin","year":"2014","journal-title":"Int J Clin Exp Med"},{"key":"2020050723442962000_73.Suppl_1.i1.61","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1038\/bjc.2015.286","article-title":"Fibulin-3 levels in malignant pleural mesothelioma are associated with prognosis but not diagnosis","volume":"113","author":"Kirschner","year":"2015","journal-title":"Br J Cancer"},{"key":"2020050723442962000_73.Suppl_1.i1.62","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-10-1929"},{"key":"2020050723442962000_73.Suppl_1.i1.63","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.lungcan.2013.09.016","article-title":"Pleural effusion hyaluronic acid as a prognostic marker in pleural malignant mesothelioma","volume":"82","author":"Creaney","year":"2013","journal-title":"Lung Cancer"},{"key":"2020050723442962000_73.Suppl_1.i1.64","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/430689"},{"key":"2020050723442962000_73.Suppl_1.i1.65","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.2013.815"},{"key":"2020050723442962000_73.Suppl_1.i1.66","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200807-1125OC"},{"key":"2020050723442962000_73.Suppl_1.i1.67","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.rmed.2010.10.010","article-title":"Pleural effusion VEGF levels as a prognostic factor of malignant pleural mesothelioma","volume":"105","author":"Hirayama","year":"2011","journal-title":"Respir Med"},{"key":"2020050723442962000_73.Suppl_1.i1.68","doi-asserted-by":"publisher","DOI":"10.1097\/JTO.0b013e3182272294"},{"key":"2020050723442962000_73.Suppl_1.i1.69","doi-asserted-by":"publisher","DOI":"10.1097\/JTO.0b013e31822a3740"},{"key":"2020050723442962000_73.Suppl_1.i1.70","doi-asserted-by":"publisher","DOI":"10.1016\/j.lungcan.2011.06.007"},{"key":"2020050723442962000_73.Suppl_1.i1.71","doi-asserted-by":"publisher","DOI":"10.1097\/JTO.0b013e31823f45c1"},{"key":"2020050723442962000_73.Suppl_1.i1.72","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1002\/1097-0142(20010901)92:5<1224::AID-CNCR1441>3.0.CO;2-U","article-title":"Hyaluronan content in pleural fluid as a prognostic factor in patients with malignant pleural mesothelioma","volume":"92","author":"Thyl\u00e9n","year":"2001","journal-title":"Cancer"},{"key":"2020050723442962000_73.Suppl_1.i1.73","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2009.26.9944"},{"key":"2020050723442962000_73.Suppl_1.i1.74","doi-asserted-by":"publisher","DOI":"10.1186\/1756-9966-32-7"},{"key":"2020050723442962000_73.Suppl_1.i1.75","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1038\/bjc.2015.62","article-title":"The South West Area Mesothelioma and Pemetrexed trial: a multicentre prospective observational study evaluating novel markers of chemotherapy response and prognostication","volume":"112","author":"Hooper","year":"2015","journal-title":"Br J Cancer"},{"key":"2020050723442962000_73.Suppl_1.i1.76","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.ejca.2016.04.018","article-title":"Circulating activin A is a novel prognostic biomarker in malignant pleural mesothelioma - A multi-institutional study","volume":"63","author":"Hoda","year":"2016","journal-title":"Eur J Cancer"},{"key":"2020050723442962000_73.Suppl_1.i1.77","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200802-258OC"},{"key":"2020050723442962000_73.Suppl_1.i1.78","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1159\/000355687","article-title":"Is soluble mesothelin-related protein an upfront predictive marker of pleural mesothelioma? A prospective study on Italian workers exposed to asbestos","volume":"86","author":"Filiberti","year":"2014","journal-title":"Oncology"},{"key":"2020050723442962000_73.Suppl_1.i1.79","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/s00408-013-9526-9","article-title":"Serum biomarkers in patients with mesothelioma and pleural plaques and healthy subjects exposed to naturally occurring asbestos","volume":"192","author":"Bayram","year":"2014","journal-title":"Lung"},{"key":"2020050723442962000_73.Suppl_1.i1.80","doi-asserted-by":"publisher","DOI":"10.1007\/s00204-010-0580-2"},{"key":"2020050723442962000_73.Suppl_1.i1.81","doi-asserted-by":"publisher","DOI":"10.1158\/1055-9965.EPI-08-0422"},{"key":"2020050723442962000_73.Suppl_1.i1.82","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2007.12.5294"},{"key":"2020050723442962000_73.Suppl_1.i1.83","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1200\/JCO.1998.16.1.145","article-title":"Prognostic factors in patients with pleural mesothelioma: the European Organization for Research and Treatment of Cancer experience","volume":"16","author":"Curran","year":"1998","journal-title":"J Clin Oncol"},{"key":"2020050723442962000_73.Suppl_1.i1.84","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.07.050"},{"key":"2020050723442962000_73.Suppl_1.i1.85","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.2013.504"},{"key":"2020050723442962000_73.Suppl_1.i1.86","doi-asserted-by":"publisher","DOI":"10.1136\/thorax.55.9.731"},{"key":"2020050723442962000_73.Suppl_1.i1.87","doi-asserted-by":"publisher","DOI":"10.1378\/chest.113.3.723"},{"key":"2020050723442962000_73.Suppl_1.i1.88","doi-asserted-by":"publisher","DOI":"10.1136\/thoraxjnl-2014-205285"},{"key":"2020050723442962000_73.Suppl_1.i1.89","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.jtho.2015.12.108","article-title":"A Novel Clinical Prediction Model for Prognosis in Malignant Pleural Mesothelioma Using Decision Tree Analysis","volume":"11","author":"Brims","year":"2016","journal-title":"J Thorac Oncol"},{"key":"2020050723442962000_73.Suppl_1.i1.90","doi-asserted-by":"crossref","first-page":"803","DOI":"10.3109\/0284186X.2012.709948","article-title":"Treatment and survival analyses of malignant mesothelioma in Japan","volume":"52","author":"Gemba","year":"2013","journal-title":"Acta Oncol"},{"key":"2020050723442962000_73.Suppl_1.i1.91","doi-asserted-by":"publisher","DOI":"10.1097\/JTO.0b013e3181f1cf2b"},{"key":"2020050723442962000_73.Suppl_1.i1.92","doi-asserted-by":"publisher","DOI":"10.1016\/j.athoracsur.2014.04.040"},{"key":"2020050723442962000_73.Suppl_1.i1.93","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(14)60418-9"},{"key":"2020050723442962000_73.Suppl_1.i1.94","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2012.5535"},{"key":"2020050723442962000_73.Suppl_1.i1.95","doi-asserted-by":"publisher","DOI":"10.1136\/thoraxjnl-2012-203043"},{"key":"2020050723442962000_73.Suppl_1.i1.96","doi-asserted-by":"publisher","DOI":"10.1007\/s00408-011-9283-6"},{"key":"2020050723442962000_73.Suppl_1.i1.97","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1843.2005.00763.x"},{"key":"2020050723442962000_73.Suppl_1.i1.98","doi-asserted-by":"crossref","first-page":"455","DOI":"10.5694\/j.1326-5377.1991.tb121175.x","article-title":"Pleurectomy for mesothelioma","volume":"154","author":"Brancatisano","year":"1991","journal-title":"Med J Aust"},{"key":"2020050723442962000_73.Suppl_1.i1.99","doi-asserted-by":"publisher","DOI":"10.1186\/1749-8090-5-27"},{"key":"2020050723442962000_73.Suppl_1.i1.100","first-page":"5131","article-title":"Improved quality of life in patients with malignant pleural effusion following videoassisted thoracoscopic talc pleurodesis. Preliminary results","volume":"32","author":"Basso","year":"2012","journal-title":"Anticancer Res"},{"key":"2020050723442962000_73.Suppl_1.i1.101","doi-asserted-by":"publisher","DOI":"10.1016\/j.lungcan.2009.02.023"},{"key":"2020050723442962000_73.Suppl_1.i1.102","doi-asserted-by":"publisher","DOI":"10.1097\/JTO.0b013e3182208e3f"},{"key":"2020050723442962000_73.Suppl_1.i1.103","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(11)70149-8"},{"key":"2020050723442962000_73.Suppl_1.i1.104","doi-asserted-by":"publisher","DOI":"10.1016\/j.athoracsur.2012.05.102"},{"key":"2020050723442962000_73.Suppl_1.i1.105","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1097\/JTO.0b013e31824de2dc","article-title":"Prospective study on functional results after lung-sparing radical pleurectomy in the management of malignant pleural mesothelioma","volume":"7","author":"B\u00f6l\u00fckbas","year":"2012","journal-title":"J Thorac Oncol"},{"key":"2020050723442962000_73.Suppl_1.i1.106","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1016\/j.athoracsur.2015.01.058","article-title":"Effects of extended pleurectomy and decortication on quality of life and pulmonary function in patients with malignant pleural mesothelioma","volume":"99","author":"Burkholder","year":"2015","journal-title":"Ann Thorac Surg"},{"key":"2020050723442962000_73.Suppl_1.i1.107","doi-asserted-by":"publisher","DOI":"10.1177\/0218492312454017"},{"key":"2020050723442962000_73.Suppl_1.i1.108","doi-asserted-by":"publisher","DOI":"10.1097\/JTO.0b013e3181ed0489"},{"key":"2020050723442962000_73.Suppl_1.i1.109","first-page":"428","article-title":"Systematic review of trimodality therapy for patients with malignant pleural mesothelioma","volume":"1","author":"Cao","year":"2012","journal-title":"Ann Cardiothorac Surg"},{"key":"2020050723442962000_73.Suppl_1.i1.110","doi-asserted-by":"publisher","DOI":"10.1016\/j.lungcan.2013.04.024"},{"key":"2020050723442962000_73.Suppl_1.i1.111","doi-asserted-by":"publisher","DOI":"10.1016\/j.lungcan.2013.11.026"},{"issue":"Suppl 1: S71","key":"2020050723442962000_73.Suppl_1.i1.112","doi-asserted-by":"crossref","first-page":"S71","DOI":"10.1016\/S0169-5002(16)30212-4","article-title":"A feasibility study comparing (extended) pleurectomy decortication versus no pleurectomy decortication in the multimodality management of patients with malignant pleural mesothelioma: the MARS 2 study","volume":"91","author":"Lim","year":"2016","journal-title":"Lung Cancer"},{"key":"2020050723442962000_73.Suppl_1.i1.113","doi-asserted-by":"publisher","DOI":"10.1097\/JTO.0b013e318286c72b"},{"key":"2020050723442962000_73.Suppl_1.i1.114","doi-asserted-by":"publisher","DOI":"10.1016\/j.athoracsur.2014.09.056"},{"key":"2020050723442962000_73.Suppl_1.i1.115","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2003.11.136"},{"key":"2020050723442962000_73.Suppl_1.i1.116","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.20005.14.589"},{"key":"2020050723442962000_73.Suppl_1.i1.117","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(08)60727-8"},{"key":"2020050723442962000_73.Suppl_1.i1.118","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S0140-6736(08)61273-8","article-title":"MVP and vinorelbine for malignant pleural mesothelioma","volume":"372","author":"Mordant","year":"2008","journal-title":"Lancet"},{"issue":"15 SUPPL. 1","key":"2020050723442962000_73.Suppl_1.i1.119","doi-asserted-by":"crossref","first-page":"7500","DOI":"10.1200\/jco.2015.33.15_suppl.7500","article-title":"Bevacizumab 15mg\/kg plus cisplatin-pemetrexed (CP) triplet versus CP doublet in Malignant Pleural Mesothelioma (MPM): Results of the IFCT-GFPC-0701 MAPS randomized phase 3 trial","volume":"33","author":"Zalcman","year":"2015","journal-title":"J of Clinical Oncology"},{"key":"2020050723442962000_73.Suppl_1.i1.120","doi-asserted-by":"publisher","DOI":"10.1097\/JTO.0b013e31817c73d6"},{"key":"2020050723442962000_73.Suppl_1.i1.121","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.lungcan.2015.06.018","article-title":"Second line therapy in malignant pleural mesothelioma: A systematic review","volume":"89","author":"Buikhuisen","year":"2015","journal-title":"Lung Cancer"},{"key":"2020050723442962000_73.Suppl_1.i1.122","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2006.09.9887"},{"key":"2020050723442962000_73.Suppl_1.i1.123","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(15)70056-2"},{"key":"2020050723442962000_73.Suppl_1.i1.124","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1016\/j.jtho.2017.02.013","article-title":"The Immune Microenvironment, Genome-wide Copy Number Aberrations, and Survival in Mesothelioma","volume":"12","author":"Thapa","year":"2017","journal-title":"J Thorac Oncol"},{"key":"2020050723442962000_73.Suppl_1.i1.125","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/S1470-2045(17)30169-9","article-title":"Clinical safety and activity of pembrolizumab in patients with malignant pleural mesothelioma (KEYNOTE-028): preliminary results from a non-randomised, open-label, phase 1b trial","volume":"18","author":"Alley","year":"2017","journal-title":"Lancet Oncol"},{"key":"2020050723442962000_73.Suppl_1.i1.126","doi-asserted-by":"publisher","DOI":"10.1378\/chest.108.3.754"},{"key":"2020050723442962000_73.Suppl_1.i1.127","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6601957"},{"key":"2020050723442962000_73.Suppl_1.i1.128","doi-asserted-by":"publisher","DOI":"10.1016\/j.radonc.2007.05.022"},{"key":"2020050723442962000_73.Suppl_1.i1.129","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(16)30095-X"},{"key":"2020050723442962000_73.Suppl_1.i1.130","doi-asserted-by":"publisher","DOI":"10.1016\/j.lungcan.2009.06.014"},{"key":"2020050723442962000_73.Suppl_1.i1.131","doi-asserted-by":"crossref","unstructured":"Bayman N , Ardron D , Ashcroft L , et al . Protocol for PIT: a phase III trial of prophylactic irradiation of tracts in patients with malignant pleural mesothelioma following invasive chest wall intervention. BMJ Open 2016;6:e010589.","DOI":"10.1136\/bmjopen-2015-010589"},{"key":"2020050723442962000_73.Suppl_1.i1.132","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.jtcvs.2015.09.129","article-title":"Accelerated hemithoracic radiation followed by extrapleural pneumonectomy for malignant pleural mesothelioma","volume":"151","author":"de Perrot","year":"2016","journal-title":"J Thorac Cardiovasc Surg"},{"key":"2020050723442962000_73.Suppl_1.i1.133","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.96.09122565"},{"key":"2020050723442962000_73.Suppl_1.i1.134","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2014.05.032"},{"key":"2020050723442962000_73.Suppl_1.i1.135","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2006.03.012"},{"key":"2020050723442962000_73.Suppl_1.i1.136","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2007.02.047"},{"key":"2020050723442962000_73.Suppl_1.i1.137","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/s11748-011-0915-9","article-title":"Induction chemotherapy, extrapleural pneumonectomy, and adjuvant radiotherapy for malignant pleural mesothelioma: experience of Guy\u2019s and St Thomas\u2019 hospitals","volume":"60","author":"Bille","year":"2012","journal-title":"Gen Thorac Cardiovasc Surg"},{"key":"2020050723442962000_73.Suppl_1.i1.138","doi-asserted-by":"publisher","DOI":"10.1016\/j.lungcan.2009.08.019"},{"key":"2020050723442962000_73.Suppl_1.i1.139","doi-asserted-by":"publisher","DOI":"10.1097\/01243894-200605000-00004"},{"key":"2020050723442962000_73.Suppl_1.i1.140","doi-asserted-by":"publisher","DOI":"10.1016\/j.radonc.2009.03.011"},{"key":"2020050723442962000_73.Suppl_1.i1.141","doi-asserted-by":"publisher","DOI":"10.1097\/JTO.0b013e318031d05c"},{"key":"2020050723442962000_73.Suppl_1.i1.142","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.1097\/JTO.0b013e318272601f","article-title":"Tomotherapy after pleurectomy\/decortication or biopsy for malignant pleural mesothelioma allows the delivery of high dose of radiation in patients with intact lung","volume":"7","author":"Minatel","year":"2012","journal-title":"J Thorac Oncol"},{"key":"2020050723442962000_73.Suppl_1.i1.143","doi-asserted-by":"publisher","DOI":"10.1016\/j.lungcan.2013.10.013"},{"key":"2020050723442962000_73.Suppl_1.i1.144","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2007.03.011"},{"key":"2020050723442962000_73.Suppl_1.i1.145","first-page":"595","article-title":"5-year prospective results of trimodality treatment for malignant pleural mesothelioma","volume":"47","author":"Pagan","year":"2006","journal-title":"J Cardiovasc Surg"},{"key":"2020050723442962000_73.Suppl_1.i1.146","doi-asserted-by":"publisher","DOI":"10.1067\/mtc.2001.116560"},{"key":"2020050723442962000_73.Suppl_1.i1.147","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.radonc.2011.09.025","article-title":"Adjuvant radiotherapy after extrapleural pneumonectomy for mesothelioma. Prospective analysis of a multi-institutional series","volume":"101","author":"Tonoli","year":"2011","journal-title":"Radiother Oncol"},{"key":"2020050723442962000_73.Suppl_1.i1.148","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00039510"},{"key":"2020050723442962000_73.Suppl_1.i1.149","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdm093"},{"key":"2020050723442962000_73.Suppl_1.i1.150","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(15)00208-9"},{"key":"2020050723442962000_73.Suppl_1.i1.151","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2016.67.2675"},{"key":"2020050723442962000_73.Suppl_1.i1.152","doi-asserted-by":"publisher","DOI":"10.1016\/S0936-6555(05)80582-5"},{"key":"2020050723442962000_73.Suppl_1.i1.153","doi-asserted-by":"publisher","DOI":"10.1097\/JTO.0000000000000499"},{"key":"2020050723442962000_73.Suppl_1.i1.154","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1673.1994.tb00177.x"},{"key":"2020050723442962000_73.Suppl_1.i1.155","doi-asserted-by":"publisher","DOI":"10.1016\/S0360-3016(98)00409-X"},{"key":"2020050723442962000_73.Suppl_1.i1.156","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2011.05.012"},{"key":"2020050723442962000_73.Suppl_1.i1.157","doi-asserted-by":"crossref","unstructured":"Chapman E , Berenstein EG , Dieguez M , et al . Radiotherapy for malignant pleural mesothelioma. Cochrane Database Syst Rev 2006;3:CD003880.","DOI":"10.1002\/14651858.CD003880.pub4"},{"key":"2020050723442962000_73.Suppl_1.i1.158","doi-asserted-by":"publisher","DOI":"10.1016\/j.lungcan.2013.11.004"},{"key":"2020050723442962000_73.Suppl_1.i1.159","doi-asserted-by":"publisher","DOI":"10.1136\/thx.54.3.238"},{"key":"2020050723442962000_73.Suppl_1.i1.160","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2008.08.009"},{"key":"2020050723442962000_73.Suppl_1.i1.161","first-page":"79","article-title":"Benefits of multidisciplinary teamwork in the management of breast cancer","volume":"5","author":"Taylor","year":"2013","journal-title":"Breast Cancer"},{"key":"2020050723442962000_73.Suppl_1.i1.162","doi-asserted-by":"publisher","DOI":"10.1200\/JOP.2014.003350"},{"key":"2020050723442962000_73.Suppl_1.i1.163","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.2013.231"},{"key":"2020050723442962000_73.Suppl_1.i1.164","doi-asserted-by":"crossref","unstructured":"Bibby AC , Williams K , Smith S , et al . What is the role of a specialist regional mesothelioma multidisciplinary team meeting? A service evaluation of one tertiary referral centre in the UK. BMJ Open 2016;6:e012092.","DOI":"10.1136\/bmjopen-2016-012092"},{"key":"2020050723442962000_73.Suppl_1.i1.165","unstructured":"NICE. Lung cancer: diagnosis and management, 2011. CG121."},{"key":"2020050723442962000_73.Suppl_1.i1.166","first-page":"1193","article-title":"Quality of life and personality traits in patients with malignant pleural mesothelioma and their first-degree caregivers","volume":"9","author":"Granieri","year":"2013","journal-title":"Neuropsychiatr Dis Treat"},{"key":"2020050723442962000_73.Suppl_1.i1.167","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1002\/pon.3162","article-title":"\u2019It\u2019s all bad news\u2019: the first 3 months following a diagnosis of malignant pleural mesothelioma","volume":"22","author":"Arber","year":"2013","journal-title":"Psychooncology"},{"key":"2020050723442962000_73.Suppl_1.i1.168","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1016\/j.hoc.2005.09.003","article-title":"Mesothelioma from the patient\u2019s perspective","volume":"19","author":"Clayson","year":"2005","journal-title":"Hematol Oncol Clin North Am"},{"key":"2020050723442962000_73.Suppl_1.i1.169","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.ejon.2016.09.007","article-title":"A systematic literature review comparing the psychological care needs of patients with mesothelioma and advanced lung cancer","volume":"25","author":"Ball","year":"2016","journal-title":"Eur J Oncol Nurs"},{"key":"2020050723442962000_73.Suppl_1.i1.170","first-page":"585","article-title":"\u2019Hands of Time\u2019: the experience of establishing a support group for people affected by mesothelioma","volume":"17","author":"Moore","year":"2008","journal-title":"Eur J Cancer Care"},{"key":"2020050723442962000_73.Suppl_1.i1.171","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1002\/ajim.22106","article-title":"Compensation of pleural mesothelioma in France: data from the French National Mesothelioma Surveillance Programme","volume":"56","author":"Chamming\u2019s","year":"2013","journal-title":"Am J Ind Med"},{"key":"2020050723442962000_73.Suppl_1.i1.172","doi-asserted-by":"publisher","DOI":"10.1002\/ajim.20705"},{"key":"2020050723442962000_73.Suppl_1.i1.173","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1097\/MAJ.0b013e3182297912","article-title":"Missed opportunities to counsel patients with malignant pleural mesothelioma about causation and potential compensation","volume":"343","author":"Kuschner","year":"2012","journal-title":"Am J Med Sci"},{"key":"2020050723442962000_73.Suppl_1.i1.174","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejrad.2009.02.002"},{"key":"2020050723442962000_73.Suppl_1.i1.175","doi-asserted-by":"publisher","DOI":"10.1097\/JTO.0000000000000211"},{"key":"2020050723442962000_73.Suppl_1.i1.176","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdh059"},{"key":"2020050723442962000_73.Suppl_1.i1.177","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2006.06.8999"},{"key":"2020050723442962000_73.Suppl_1.i1.178","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00146110"},{"key":"2020050723442962000_73.Suppl_1.i1.179","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1248\/jhs.53.23","article-title":"Mustaffer Metintas Relationship between tumour size of MPM and its response to chemotherapy","volume":"53","author":"Hilmi Ozden","year":"2007","journal-title":"Journal of Health Science"},{"issue":"Suppl 1","key":"2020050723442962000_73.Suppl_1.i1.180","doi-asserted-by":"crossref","first-page":"S37","DOI":"10.1016\/j.lungcan.2005.03.030","article-title":"CT, RECIST, and malignant pleural mesothelioma","volume":"49","author":"Nowak","year":"2005","journal-title":"Lung Cancer"},{"key":"2020050723442962000_73.Suppl_1.i1.181","doi-asserted-by":"publisher","DOI":"10.1007\/s00330-008-0918-9"},{"key":"2020050723442962000_73.Suppl_1.i1.182","doi-asserted-by":"publisher","DOI":"10.1016\/S0169-5002(03)00292-7"},{"key":"2020050723442962000_73.Suppl_1.i1.183","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdh059"},{"key":"2020050723442962000_73.Suppl_1.i1.184","doi-asserted-by":"publisher","DOI":"10.1007\/s00330-008-0918-9"},{"key":"2020050723442962000_73.Suppl_1.i1.185","unstructured":"NICE. Suspected cancer: recognition and referral, 2015. NG 12."},{"key":"2020050723442962000_73.Suppl_1.i1.186","doi-asserted-by":"publisher","DOI":"10.1097\/00000478-200101000-00004"},{"key":"2020050723442962000_73.Suppl_1.i1.187","doi-asserted-by":"publisher","DOI":"10.1080\/00313020802579250"},{"key":"2020050723442962000_73.Suppl_1.i1.188","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2559.2003.01583.x"},{"key":"2020050723442962000_73.Suppl_1.i1.189","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1038\/modpathol.2012.172","article-title":"Mesothelioma with signet-ring cell features: report of 23 cases","volume":"26","author":"Ord\u00f3\u00f1ez","year":"2013","journal-title":"Mod Pathol"},{"key":"2020050723442962000_73.Suppl_1.i1.190","doi-asserted-by":"publisher","DOI":"10.1309\/QHCA-8594-TA7P-0DVQ"},{"key":"2020050723442962000_73.Suppl_1.i1.191","doi-asserted-by":"publisher","DOI":"10.1097\/00000478-200604000-00006"},{"key":"2020050723442962000_73.Suppl_1.i1.192","doi-asserted-by":"publisher","DOI":"10.1053\/hupa.2001.24329"},{"key":"2020050723442962000_73.Suppl_1.i1.193","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1096-9896(199910)189:2<251::AID-PATH412>3.0.CO;2-F"},{"key":"2020050723442962000_73.Suppl_1.i1.194","doi-asserted-by":"publisher","DOI":"10.1038\/modpathol.3880018"},{"key":"2020050723442962000_73.Suppl_1.i1.195","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2559.2009.03298.x"},{"key":"2020050723442962000_73.Suppl_1.i1.196","doi-asserted-by":"publisher","DOI":"10.1309\/XL6K-8E62-9FLD-V8Q8"},{"key":"2020050723442962000_73.Suppl_1.i1.197","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.22477"},{"key":"2020050723442962000_73.Suppl_1.i1.198","doi-asserted-by":"publisher","DOI":"10.1097\/00000478-200302000-00002"},{"key":"2020050723442962000_73.Suppl_1.i1.199","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2559.1998.00349.x"},{"key":"2020050723442962000_73.Suppl_1.i1.200","doi-asserted-by":"publisher","DOI":"10.1038\/modpathol.2009.180"},{"key":"2020050723442962000_73.Suppl_1.i1.201","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0344-0338(96)80208-1","article-title":"The calcium binding protein calretinin is a selective marker for malignant pleural mesotheliomas of the epithelial type","volume":"192","author":"Gotzos","year":"1996","journal-title":"Pathol Res Pract"},{"key":"2020050723442962000_73.Suppl_1.i1.202","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1111\/j.1365-2559.1996.tb01393.x","article-title":"Mesothelioma-binding antibodies: thrombomodulin, OV 632 and HBME-1 and their use in the diagnosis of malignant mesothelioma","volume":"29","author":"Attanoos","year":"1996","journal-title":"Histopathology"},{"key":"2020050723442962000_73.Suppl_1.i1.203","doi-asserted-by":"publisher","DOI":"10.1016\/0046-8177(93)90080-Z"},{"key":"2020050723442962000_73.Suppl_1.i1.204","first-page":"827","article-title":"Thrombomodulin expression in malignant pleural mesothelioma and pulmonary adenocarcinoma","volume":"141","author":"Collins","year":"1992","journal-title":"Am J Pathol"},{"key":"2020050723442962000_73.Suppl_1.i1.205","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1111\/j.1699-0463.1997.tb05099.x","article-title":"Optimization of a battery using nine immunocytochemical variables for distinguishing between epithelial mesothelioma and adenocarcinoma","volume":"105","author":"Dejmek","year":"1997","journal-title":"APMIS"},{"key":"2020050723442962000_73.Suppl_1.i1.206","doi-asserted-by":"publisher","DOI":"10.1002\/dc.20202"},{"key":"2020050723442962000_73.Suppl_1.i1.207","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0142(19980425)84:2<101::AID-CNCR6>3.0.CO;2-S"},{"key":"2020050723442962000_73.Suppl_1.i1.208","doi-asserted-by":"publisher","DOI":"10.1097\/00000478-199712000-00002"},{"key":"2020050723442962000_73.Suppl_1.i1.209","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2559.1997.6020829.x"},{"key":"2020050723442962000_73.Suppl_1.i1.210","doi-asserted-by":"publisher","DOI":"10.1136\/jcp.50.10.859"},{"key":"2020050723442962000_73.Suppl_1.i1.211","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2559.1997.2150833.x"},{"key":"2020050723442962000_73.Suppl_1.i1.212","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2559.2001.01157.x"},{"key":"2020050723442962000_73.Suppl_1.i1.213","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0339(199708)17:2<115::AID-DC6>3.0.CO;2-F"},{"key":"2020050723442962000_73.Suppl_1.i1.214","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2559.1998.00405.x"},{"key":"2020050723442962000_73.Suppl_1.i1.215","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2303.2000.00211.x"},{"key":"2020050723442962000_73.Suppl_1.i1.216","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1002\/dc.20486","article-title":"The high post-test probability of a cytological examination renders further investigations to establish a diagnosis of epithelial malignant pleural mesothelioma redundant","volume":"34","author":"Aerts","year":"2006","journal-title":"Diagn Cytopathol"},{"key":"2020050723442962000_73.Suppl_1.i1.217","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1183\/09031936.93.03090997","article-title":"Vimentin, carcinoembryonic antigen and keratin in the diagnosis of mesothelioma, adenocarcinoma and reactive pleural lesions","volume":"3","author":"al-Saffar","year":"1990","journal-title":"Eur Respir J"},{"key":"2020050723442962000_73.Suppl_1.i1.218","doi-asserted-by":"publisher","DOI":"10.1016\/0046-8177(90)90036-5"},{"key":"2020050723442962000_73.Suppl_1.i1.219","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1053\/j.anndiagpath.2004.08.003","article-title":"TTF-1 and surfactant-B as co-adjuvants in the diagnosis of lung adenocarcinoma and pleural mesothelioma","volume":"8","author":"Bakir","year":"2004","journal-title":"Ann Diagn Pathol"},{"key":"2020050723442962000_73.Suppl_1.i1.220","doi-asserted-by":"publisher","DOI":"10.1016\/S0304-3835(97)00466-7"},{"key":"2020050723442962000_73.Suppl_1.i1.221","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2559.2003.01686.x"},{"key":"2020050723442962000_73.Suppl_1.i1.222","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2559.1996.d01-562.x"},{"key":"2020050723442962000_73.Suppl_1.i1.223","doi-asserted-by":"publisher","DOI":"10.1097\/00000478-200004000-00016"},{"key":"2020050723442962000_73.Suppl_1.i1.224","doi-asserted-by":"publisher","DOI":"10.1016\/0046-8177(94)90115-5"},{"key":"2020050723442962000_73.Suppl_1.i1.225","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.lungcan.2013.12.009","article-title":"How useful is GLUT-1 in differentiating mesothelial hyperplasia and fibrosing pleuritis from epithelioid and sarcomatoid mesotheliomas? An international collaborative study","volume":"83","author":"Husain","year":"2014","journal-title":"Lung Cancer"},{"key":"2020050723442962000_73.Suppl_1.i1.226","doi-asserted-by":"publisher","DOI":"10.1038\/modpathol.3800732"},{"key":"2020050723442962000_73.Suppl_1.i1.227","doi-asserted-by":"publisher","DOI":"10.1309\/AJCPM2Z4NGIIPBGE"},{"key":"2020050723442962000_73.Suppl_1.i1.228","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1002\/cncy.21392","article-title":"Claudin-4 immunohistochemistry is highly effective in distinguishing adenocarcinoma from malignant mesothelioma in effusion cytology","volume":"122","author":"Jo","year":"2014","journal-title":"Cancer Cytopathol"},{"key":"2020050723442962000_73.Suppl_1.i1.229","doi-asserted-by":"publisher","DOI":"10.1016\/j.humpath.2005.01.019"},{"key":"2020050723442962000_73.Suppl_1.i1.230","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1115050"},{"key":"2020050723442962000_73.Suppl_1.i1.231","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.ejcdt.2013.10.004","article-title":"Role of fibulin-3 in the diagnosis of malignant mesothelioma","volume":"63","author":"Agha","year":"2014","journal-title":"Egypt J Chest Dis Tuberc"},{"key":"2020050723442962000_73.Suppl_1.i1.232","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.ejcdt.2014.08.001","article-title":"Value of plasma and pleural effusion fibulin-3 levels in the diagnosis of malignant pleural mesothelioma effusions","volume":"63","author":"Elgazzar","year":"2014","journal-title":"Egypt J Chest Dis Tuberc"},{"key":"2020050723442962000_73.Suppl_1.i1.233","doi-asserted-by":"publisher","DOI":"10.1136\/thoraxjnl-2014-205205"},{"key":"2020050723442962000_73.Suppl_1.i1.234","doi-asserted-by":"publisher","DOI":"10.1136\/thorax.57.11.939"},{"key":"2020050723442962000_73.Suppl_1.i1.235","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.327.7414.523"},{"key":"2020050723442962000_73.Suppl_1.i1.236","first-page":"CD005623","article-title":"Non-pharmacological interventions for breathlessness in advanced stages of malignant and non-malignant diseases","volume":"2","author":"Bausewein","year":"2008","journal-title":"Cochrane Database Syst Rev"},{"key":"2020050723442962000_73.Suppl_1.i1.237","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpainsymman.2009.09.024"},{"key":"2020050723442962000_73.Suppl_1.i1.238","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(14)70226-7"},{"key":"2020050723442962000_73.Suppl_1.i1.239","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-014-0194-2"},{"key":"2020050723442962000_73.Suppl_1.i1.240","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(12)70040-2"},{"key":"2020050723442962000_73.Suppl_1.i1.241","unstructured":"NICE. Opiods in palliative care:safe and effective prescribing of strong opiods in palliative care of adults, 2012. CG 140."},{"key":"2020050723442962000_73.Suppl_1.i1.242","unstructured":"NICE. Neuropathic pain - pharmacological management, 2013. CG 173."},{"key":"2020050723442962000_73.Suppl_1.i1.243","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(14)70251-0"},{"key":"2020050723442962000_73.Suppl_1.i1.244","doi-asserted-by":"crossref","unstructured":"Cramp F , Daniel J . Exercise for the management of cancer-related fatigue in adults. Cochrane database of systematic reviews (Online). Cochrane Database Syst Rev 2012;11:CD006145.","DOI":"10.1002\/14651858.CD006145.pub3"},{"key":"2020050723442962000_73.Suppl_1.i1.245","doi-asserted-by":"crossref","unstructured":"Ruiz Garcia V , L\u00f3pez-Briz E , Carbonell Sanchis R , et al . Megestrol acetate for treatment of anorexia-cachexia syndrome. Cochrane Database Syst Rev 2013;9:CD004310","DOI":"10.1002\/14651858.CD004310.pub3"}],"container-title":["Thorax"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/thoraxjnl-2017-211321","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T06:04:07Z","timestamp":1719813847000},"score":1,"resource":{"primary":{"URL":"https:\/\/thorax.bmj.com\/lookup\/doi\/10.1136\/thoraxjnl-2017-211321"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2,14]]},"references-count":245,"journal-issue":{"issue":"Suppl 1","published-online":{"date-parts":[[2018,2,14]]},"published-print":{"date-parts":[[2018,3]]}},"alternative-id":["10.1136\/thoraxjnl-2017-211321"],"URL":"https:\/\/doi.org\/10.1136\/thoraxjnl-2017-211321","relation":{"has-part":[{"id-type":"doi","id":"https:\/\/doi.org\/10.1136\/thoraxjnl-2017-211321.supp1","asserted-by":"subject"},{"id-type":"doi","id":"https:\/\/doi.org\/10.1136\/thoraxjnl-2017-211321.supp1","asserted-by":"subject"}]},"ISSN":["0040-6376","1468-3296"],"issn-type":[{"value":"0040-6376","type":"print"},{"value":"1468-3296","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,2,14]]}}}